Operating Lease, Liability in USD of Monopar Therapeutics from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Monopar Therapeutics quarterly Operating Lease, Liability history and growth rate from Q1 2021 to Q3 2025.
  • Monopar Therapeutics Operating Lease, Liability for the quarter ending September 30, 2025 was $102K.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)

Monopar Therapeutics Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $102K +$102K Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $114K +$114K Jun 30, 2025 10-Q 2025-08-12
Q3 2024 $0 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 $0 Jun 30, 2024 10-Q 2025-08-12
Q4 2023 $8.41K -$48.6K -85.2% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $57K +$57K Dec 31, 2022 10-K 2024-03-28
Q3 2022 $68.7K +$68.7K Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $80.1K +$80.1K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $51.3K +$51.3K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $0 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $0 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.